157 related articles for article (PubMed ID: 26237439)
1. IPF, comorbidities and management implications.
Vancheri C; Cottin V; Kreuter M; Hilberg O
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Aug; 32 Suppl 1():17-23. PubMed ID: 26237439
[TBL] [Abstract][Full Text] [Related]
2. Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.
Sangani R; Ghio A; Culp S; Patel Z; Sharma S
Int J Chron Obstruct Pulmon Dis; 2021; 16():1873-1885. PubMed ID: 34188464
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features and Outcomes of Combined Pulmonary Fibrosis and Emphysema After Lung Transplantation.
Takahashi T; Terada Y; Pasque MK; Liu J; Byers DE; Witt CA; Nava RG; Puri V; Kozower BD; Meyers BF; Kreisel D; Patterson GA; Hachem RR
Chest; 2021 Nov; 160(5):1743-1750. PubMed ID: 34186034
[TBL] [Abstract][Full Text] [Related]
4. Development of a nomogram for predicting the presence of combined pulmonary fibrosis and emphysema.
Yuan X; Jin J; Xu X
BMC Pulm Med; 2021 Nov; 21(1):349. PubMed ID: 34743726
[TBL] [Abstract][Full Text] [Related]
5. An increased risk of pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema: a meta-analysis.
Ni H; Wei Y; Yang L; Wang Q
BMC Pulm Med; 2023 Jun; 23(1):221. PubMed ID: 37344866
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry.
Kim HJ; Snyder LD; Neely ML; Hellkamp AS; Hotchkin DL; Morrison LD; Bender S; Leonard TB; Culver DA;
Lung; 2022 Feb; 200(1):21-29. PubMed ID: 34997268
[TBL] [Abstract][Full Text] [Related]
7. Mortality surrogates in combined pulmonary fibrosis and emphysema.
Zhao A; Gudmundsson E; Mogulkoc N; van Moorsel C; Corte TJ; Vasudev P; Romei C; Chapman R; Wallis TJM; Denneny E; Goos T; Savas R; Ahmed A; Brereton CJ; van Es HW; Jo H; De Liperi A; Duncan M; Pontoppidan K; De Sadeleer LJ; van Beek F; Barnett J; Cross G; Procter A; Veltkamp M; Hopkins P; Moodley Y; Taliani A; Taylor M; Verleden S; Tavanti L; Vermant M; Nair A; Stewart I; Janes SM; Young AL; Barber D; Alexander DC; Porter JC; Wells AU; Jones MG; Wuyts WA; Jacob J
Eur Respir J; 2024 Apr; 63(4):. PubMed ID: 37973176
[TBL] [Abstract][Full Text] [Related]
8. Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema.
Yamamoto Y; Hirata H; Shiroyama T; Kuge T; Matsumoto K; Yoneda M; Yamamoto M; Naito Y; Suga Y; Fukushima K; Miyake K; Koyama S; Iwahori K; Nagatomo I; Takeda Y; Kumanogoh A
Int J Chron Obstruct Pulmon Dis; 2022; 17():1495-1506. PubMed ID: 35801120
[TBL] [Abstract][Full Text] [Related]
9. Differential Genomic Profile in
Guzmán-Vargas J; Ambrocio-Ortiz E; Pérez-Rubio G; Ponce-Gallegos MA; Hernández-Zenteno RJ; Mejía M; Ramírez-Venegas A; Buendia-Roldan I; Falfán-Valencia R
Front Med (Lausanne); 2021; 8():725144. PubMed ID: 34490311
[No Abstract] [Full Text] [Related]
10. Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease.
Choi JY; Song JW; Rhee CK
Tuberc Respir Dis (Seoul); 2022 Apr; 85(2):122-136. PubMed ID: 35385639
[TBL] [Abstract][Full Text] [Related]
11. Examining prevalence and predictors of pulmonary hypertension in adults with idiopathic pulmonary fibrosis: a population-based analysis in the United States.
Desai R; Katukuri N; Kanagala SG; Ghadge N; James A; Tajdin B; Nalla A; Vutukuru SD; Kotharu DM; Kadiyala A; Vyas A; Prajjwal P; Ogbu I
J Med Life; 2024 Jan; 17(1):35-40. PubMed ID: 38737661
[TBL] [Abstract][Full Text] [Related]
12. Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study.
Jovanovic DM; Šterclová M; Mogulkoc N; Lewandowska K; Müller V; Hájková M; Studnicka M; Tekavec-Trkanjec J; Littnerová S; Vašáková M;
Respir Res; 2022 May; 23(1):135. PubMed ID: 35624513
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe.
Karampitsakos T; Spagnolo P; Mogulkoc N; Wuyts WA; Tomassetti S; Bendstrup E; Molina-Molina M; Manali ED; Unat ÖS; Bonella F; Kahn N; Kolilekas L; Rosi E; Gori L; Ravaglia C; Poletti V; Daniil Z; Prior TS; Papanikolaou IC; Aso S; Tryfon S; Papakosta D; Tzilas V; Balestro E; Papiris S; Antoniou K; Bouros D; Wells A; Kreuter M; Tzouvelekis A
Respirology; 2023 Jan; 28(1):56-65. PubMed ID: 36117239
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis.
Loomis-King H; Flaherty KR; Moore BB
Curr Opin Pharmacol; 2013 Jun; 13(3):377-85. PubMed ID: 23602652
[TBL] [Abstract][Full Text] [Related]
15. Screening for idiopathic pulmonary fibrosis using comorbidity signatures in electronic health records.
Onishchenko D; Marlowe RJ; Ngufor CG; Faust LJ; Limper AH; Hunninghake GM; Martinez FJ; Chattopadhyay I
Nat Med; 2022 Oct; 28(10):2107-2116. PubMed ID: 36175678
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and management of combined post- and precapillary pulmonary hypertension in a patient with multiple comorbidities.
Panagiotidou E; Boutou A; Kalamara E; Sourla E; Chatzopoulos E; Stanopoulos I; Pitsiou G
Adv Respir Med; 2021; 89(4):444-447. PubMed ID: 34269398
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection.
Perrotta F; Chino V; Allocca V; D'Agnano V; Bortolotto C; Bianco A; Corsico AG; Stella GM
Expert Rev Respir Med; 2022 Oct; 16(10):1043-1055. PubMed ID: 36369920
[TBL] [Abstract][Full Text] [Related]
18. Real-world practice of idiopathic pulmonary fibrosis: Results from a 2000-2016 cohort.
Wang YT; Shen TC; Lin CL; Tu CY; Hsia TC; Hsu WH
Open Med (Wars); 2023; 18(1):20230852. PubMed ID: 38025536
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of IPF patients with comorbid lung cancer: Preventing immortal time bias will make the analysis more valuable.
Yamada S; Ikeda S; Misumi T; Sekine A; Ogura T
Respirology; 2023 Feb; 28(2):196-197. PubMed ID: 36509428
[No Abstract] [Full Text] [Related]
20. Impact of pulmonary hypertension on lung cancer management.
Durin L; Noël-Savina E; Héluain V; Mattei P; Mazières J; Prévot G
Respir Med Res; 2022 Nov; 82():100964. PubMed ID: 36283326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
